Sessioni Comunicazioni Orali


Pharmacology of antineoplastic drugs - Session I

Martedì 27 Ottobre 2015 / 14.00-16.00
64Prevention of colon carcinogenesis with a combination of Sulindac, 3,3’-diindolylmethane and Curcumin or Polyethylene Glycol in Apc-mutated Pirc rats
Femia AP., Caderni G.
173Pro-apoptotic and anti-tumoral activities of vinyl disulfides from Ferula assa-foetida L. in melanoma
Panza E., Armogida C., De Cicco P., Ercolano G., Camerlingo R., Pirozzi G., Taglialatela-Scafati O., Cirino G., Ianaro A.
155NAMI-A controls the HCT-116 CRC invasion processes through the modulation of a5b1 integrin expression and activation
Pelillo C., Mollica H., Eble J., Herzog L., Codan B., Sava G., Bergamo A.
458In vitro cell growth inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on human tumor cell lines with defective DNA damage response pathways
Nobili S., Landini I., Lucarini L., Masini E., Moroni F., Mini E.
469Differential anti-tumor and cardiovascular effects of Trastuzumab and T-DM1 in a xenotransplant model of NSCLC
Gervasi A., Madeddu D., Frati C., Lorusso B., Falco A., Graiani G., Schirripa ML., Ricci P., Cretella D., Saccani F., Alfieri R., Lagrasta CA., Quaini F.
518ANXA1 is involved in the acquisition of an aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid
Bizzarro V., Belvedere R., Milone MR., Pucci B., Lombardi R., Bruzzese F., Popolo A., Parente L., Budillon A., Petrella A.
700A promising biomarker of early cancer detection: the liquid biopsy
Malara NM., Trunzo V., Mignogna C., Camastra C., Fini M., Donato G., Mollace V.
415Microglia polarization in neuro-oncology
Laudati E., Dello Russo C., Navarra P., Lisi L.